WHP Health

Clinical Research Services 

Women's Health Practice offers women a unique opportunity to participate in leading research projects.

Studies are under the careful review of Institutional Review Boards to ensure research participant safety. As Director of the Department of Obstetrics and Gynecology at the University of Illinois College of Medicine for over 10 years, Dr. Suzanne Trupin has extensive experience supervising successful health studies.

Stipends are paid for time and travel. Study visits, treatments, and tests are covered services at no expense. For more information, please contact Treina Smith at (217) 356-3736 or email Treina and reference the study you are interested in.

Clinical Research Services

A research study for women with endometriosis pain.

The Equinox Study is evaluating an oral investigational medication to see if it may reduce moderate to severe endometriosis pain. You may qualify if you:

  • Are a premenopausal woman between the ages of 18 and 49
  • Have had a surgical diagnosis of endometriosis within the last 10 years
  • Have moderate to severe pain from endometriosis
  • Are not pregnant or actively trying to get pregnant
  • Do not have osteoporosis (thinning, weak bones) or any other bone disease
  • There are other requirements for the study

Introducing a research study to test whether an investigational drug that targets specific female hormones could help women with heavy bleeding due to fibroids.

Who can participate?

  • Women aged 18 and older with no major health problems
  • Must suffer from heavy menstrual bleeding due to uterine fibroids
  • Not planning to become pregnant in the next two years
Why participate?
  • There is a need for more effective and well-tolerated treatments for heavy bleeding due to fibroids.
  • Current medical treatments are limited in duration, and long-term options are mainly surgical.
  • You may be able to contribute to scientific developments that may lead to new treatment options.
What can you expect?
  • Study duration of approximately 85 weeks with up to 13 in-clinic visits, plus calls as needed
  • Study medication is an oral tablet taken daily for up to 52 weeks
  • Study-related procedures include: Vital signs, blood draws, physical and gynecological exams by the study physician, bone mineral density testing and questionnaires
  • Monitoring of your health by a study physician during the clinical study
  • Use of an electronic diary (we will provide this to you) to keep track of your daily bleeding
  • Qualified participants will be compensated for time and travel expenses
  • Study-related care, tests, study medication and sanitary protection will be provided to participants at no cost
  • You do not need health insurance to participate.

The Vesta clinical research study is for women who have several hot flashes daily. The purpose of the Vesta clinical research study is to determine if the investigational medication will reduce the number of daily hot flashes.

Call us at 217-356-3736 for more information!


The "RADAR-PGx", Pharmacogenomic Test Assessment for Medication Management in the Advancement of Personalized Medicine" is a research study to collect data to see if the use of pharmacogenomics (PGx) test data will help to better manage the medications that you are on and the side effects you may experience.